AzTrials
AzTrials

Rapid Sequence InductionNCT04312425

Classic and Modified Rapid Sequence Induction for Prevention of Gastric Content Regurgitation

An observational study of Rapid Sequence Induction, run by The First Affiliated Hospital with Nanjing Medical University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Induction of anesthesia induces a loss of protective upper airway reflexes and is associated with gastric content regurgitation. Emergency surgery bears a higher risk of gastric content regurgitation because of full stomach, delayed gastric emptying, intestinal obstruction, stroke or other factors. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Rapid Sequence Induction
What is being tested?
Modified rapid sequence induction and Classic rapid sequence induction
Type of treatment
Surgery or procedure
How many people
8,601 participants
Where
1 siteChina
Study dates
5 Mar 2020to 15 Mar 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients receive emergency surgery under general anesthesia.

Who may be able to join

  • Patients receive emergency surgery under general anesthesia March 1, 2015 to February 29, 2020
  • Eighteen years or older

Who cannot join

  • Trachea intubation status on admission
  • Tracheotomy
  • Bronchoscope surgery
  • General anesthesia with laryngeal mask
  • Awake intubation

Trial locations and contacts

1 site in 1 country.

China1 site
  • The First Affiliated Hospital of Nanjing Medical University

    Nanjing, Jiangsu, 210029

Other trials in China

About this study

Official title: Comparison of Classic and Modified Rapid Sequence Induction on Prevention of Perioperative Gastric Content Regurgitation in Emergency Surgery Under General Anesthesia

Induction of anesthesia induces a loss of protective upper airway reflexes and is associated with gastric content regurgitation. Emergency surgery bears a higher risk of gastric content regurgitation because of full stomach, delayed gastric emptying, intestinal obstruction, stroke or other factors. Rapid sequence induction (RSI) of anesthesia was recommended to minimize the risk of regurgitation and aspiration. Classic RSI scheme mainly includes the use of short-acting sedatives and muscle relaxant, together with a manual pressure to the cricoid cartilage (Sellick maneuver) which aims at compressing the esophagus to avoid regurgitation. Though widely recommended, the scheme has been controversial for years. Our department modified the scheme and put it into use in day shift emergency surgery since March 1, 2018. This retrospective analysis is aimed at comparing the effect of classic and modified rapid sequence induction in prevention of gastric content regurgitation in emergency surgery under general anesthesia.

Being tested
Modified rapid sequence induction, Classic rapid sequence induction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Modified rapid sequence inductionProcedure or surgery

    Modified RSI was put into use in day shift emergency surgery since March 1, 2018. In this scheme, dorsal elevated position and apneic oxygenation technic are applied. Positive pressure mask ventilation is avoided unless necessary. Sellick's technic is not used in this scheme.

  • Classic rapid sequence inductionProcedure or surgery

    In classic RSI scheme, patients are in supine position during induction and intubation. Sellick's technic is applied after sedatives and muscle relaxant are given.

Study groups in NCT04312425
Study groupRoleWhat they receive
Group CGeneral anesthesia was induced with classic rapid sequence induction protocol.
Receives: Procedure: Classic rapid sequence induction
Group MGeneral anesthesia was induced with modified rapid sequence induction protocol.
Receives: Procedure: Modified rapid sequence induction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of gastric content regurgitation

    The Electronic Anesthesia Record System files contained the word "aspiration" and/or "gastric content" were extracted and carefully evaluated. The events of gastric content regurgitation on admission or observed during tracheal intubation were recorded and analyzed.

    Measured: From entering operation room to endotracheal intubation completed.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2020
  2. Study start5 Mar 2020
  3. Primary completion8 Mar 2020
  4. Study completion15 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
8,601 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04312425
Sponsor's protocol ID
2020-SR-093
Status last verified
Mar 2020
First submitted
16 Mar 2020
Last updated
18 Mar 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Rapid Sequence Induction, run by The First Affiliated Hospital with Nanjing Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of gastric content regurgitation (time frame: From entering operation room to endotracheal intubation completed.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in